|
humans |
22 |
|
adult |
18 |
|
female |
17 |
|
middle aged |
17 |
|
male |
16 |
|
aged |
14 |
|
hong kong |
11 |
|
oral health |
11 |
|
follow-up studies |
10 |
|
risk factors |
9 |
|
c. albicans |
8 |
|
cohort studies |
8 |
|
diabetes mellitus, type 2 - complications |
8 |
|
dmf index |
8 |
|
health status |
8 |
|
periodontal index |
8 |
|
biofilm |
7 |
|
internet in education. |
7 |
|
kidney transplantation |
7 |
|
microbiology |
7 |
|
polymerase chain reaction |
7 |
|
problem-based learning. |
7 |
|
university of hong kong. faculty of dentistry. |
7 |
|
adolescent |
6 |
|
age factors |
6 |
|
china |
6 |
|
china - ethnology |
6 |
|
dental pulp cavity - microbiology |
6 |
|
diabetes mellitus |
6 |
|
epstein-barr virus |
6 |
|
medical sciences |
6 |
|
mouth - microbiology |
6 |
|
periapical periodontitis - microbiology |
6 |
|
prospective studies |
6 |
|
saliva |
6 |
|
aged, 80 and over |
5 |
|
amphotericin b - therapeutic use |
5 |
|
anaerobic bacteria |
5 |
|
animals |
5 |
|
anti-bacterial agents - pharmacology |
5 |
|
antibiotics |
5 |
|
antifungal agents - therapeutic use |
5 |
|
apical periodontitis |
5 |
|
bacteria, anaerobic - drug effects - isolation & purification |
5 |
|
blood glucose - analysis |
5 |
|
calcium chloride |
5 |
|
calcium hydroxide |
5 |
|
calcium hydroxide - pharmacology |
5 |
|
candida - classification |
5 |
|
candida albicans |
5 |
|
candida albicans - enzymology - isolation & purification |
5 |
|
candidiasis - microbiology |
5 |
|
chinese |
5 |
|
colony count, microbial |
5 |
|
cross-sectional studies |
5 |
|
cyclosporine - therapeutic use |
5 |
|
demeclocycline - pharmacology |
5 |
|
dental caries |
5 |
|
dental plaque - microbiology |
5 |
|
diabetes complications |
5 |
|
drug combinations |
5 |
|
endodontic treatment |
5 |
|
enterobacteriaceae - classification |
5 |
|
fungal infection |
5 |
|
gingival overgrowth |
5 |
|
gingival overgrowth - chemically induced - classification |
5 |
|
gingival overgrowth - chemically induced - complications - microbiology |
5 |
|
gram-negative aerobic rods and cocci - classification |
5 |
|
gram-negative bacteria - drug effects |
5 |
|
gram-negative facultatively anaerobic rods - classification |
5 |
|
gram-positive bacteria - drug effects |
5 |
|
hemoglobin a, glycosylated - analysis |
5 |
|
hemolysin proteins - biosynthesis |
5 |
|
hiv infection |
5 |
|
hypertension - complications |
5 |
|
immunocompromised host |
5 |
|
immunosuppressive agents - adverse effects |
5 |
|
immunosuppressive agents - therapeutic use |
5 |
|
neomycin - pharmacology |
5 |
|
peptide hydrolases - biosynthesis |
5 |
|
periodontal attachment loss - complications |
5 |
|
periodontal disease |
5 |
|
periodontal diseases |
5 |
|
periodontal diseases - therapy |
5 |
|
periodontitis - complications |
5 |
|
periodontitis - complications - microbiology |
5 |
|
polymyxin b - pharmacology |
5 |
|
potassium chloride |
5 |
|
poverty |
5 |
|
root canal irrigants - pharmacology |
5 |
|
sex factors |
5 |
|
sodium bicarbonate |
5 |
|
sodium chloride |
5 |
|
statistics as topic |
5 |
|
steroid |
5 |
|
tacrolimus - therapeutic use |
5 |
|
titanium |
5 |
|
transplantation, homologous |
5 |
|
triamcinolone acetonide - pharmacology |
5 |
|
type 2 diabetes mellitus |
5 |
|
tyrothricin - pharmacology |
5 |
|
actinomyces - classification - isolation & purification |
4 |
|
actinomycetes |
4 |
|
actinomycosis - microbiology |
4 |
|
adhesion |
4 |
|
antimicrobial agents/inhibitors |
4 |
|
bacteria, anaerobic - isolation & purification |
4 |
|
bacterial infections - microbiology |
4 |
|
confidence intervals |
4 |
|
dental caries - microbiology |
4 |
|
dental pulp diseases - microbiology |
4 |
|
dental pulp exposure - microbiology |
4 |
|
dental pulp necrosis - microbiology |
4 |
|
dna |
4 |
|
dna, bacterial - analysis |
4 |
|
fungi |
4 |
|
genotype |
4 |
|
infection |
4 |
|
nasopharyngeal carcinoma |
4 |
|
nucleic acid hybridization |
4 |
|
odds ratio |
4 |
|
oligonucleotide probes |
4 |
|
oligonucleotide-dna hybridization |
4 |
|
rna, ribosomal, 16s - analysis |
4 |
|
root canal infection |
4 |
|
tooth injuries - microbiology |
4 |
|
active penetration |
3 |
|
adherence and colonization |
3 |
|
aids-related opportunistic infections - drug therapy - microbiology |
3 |
|
aids-related opportunistic infections - microbiology |
3 |
|
analysis of variance |
3 |
|
antifungal susceptibility testing |
3 |
|
asian continental ancestry group |
3 |
|
attitude to health |
3 |
|
b-lymphocytes - virology |
3 |
|
binary titanium alloy |
3 |
|
candida |
3 |
|
candida albicans - classification - drug effects |
3 |
|
candidiasis, oral - drug therapy - microbiology |
3 |
|
carcinogen |
3 |
|
clinical trial |
3 |
|
coronavirus pneumonia infection |
3 |
|
cross infection - prevention & control - psychology - transmission |
3 |
|
cross-over studies |
3 |
|
cytokine |
3 |
|
delayed-action preparations |
3 |
|
delivery of health care - economics - trends |
3 |
|
dental care |
3 |
|
dental office |
3 |
|
dental service, hospital |
3 |
|
developing countries |
3 |
|
diagnostics |
3 |
|
disease outbreaks |
3 |
|
disinfection/sterilization |
3 |
|
drug resistance, microbial - genetics |
3 |
|
endocytosis |
3 |
|
ethnic groups |
3 |
|
eye protective devices |
3 |
|
financing, government - economics - trends |
3 |
|
financing, personal - economics - trends |
3 |
|
fluconazole - therapeutic use |
3 |
|
forecasting |
3 |
|
gels |
3 |
|
genetics |
3 |
|
growth & development |
3 |
|
health care reform - economics |
3 |
|
health expenditures - statistics & numerical data - trends |
3 |
|
health knowledge, attitudes, practice |
3 |
|
health policy - economics |
3 |
|
health status indicators |
3 |
|
health-related quality of life |
3 |
|
herpesvirus 4, human - physiology |
3 |
|
hiv infections - complications |
3 |
|
hiv-infection |
3 |
|
hong kong - epidemiology |
3 |
|
hospitals, teaching |
3 |
|
host-microbial interactions |
3 |
|
infection control, dental - instrumentation - methods |
3 |
|
interactome |
3 |
|
interviews as topic |
3 |
|
ketoconazole - therapeutic use |
3 |
|
lasers and microbiology |
3 |
|
logistic models |
3 |
|
lubricating device |
3 |
|
management |
3 |
|
masks |
3 |
|
medical devices |
3 |
|
metabolism |
3 |
|
metastatsis |
3 |
|
microbiology and oral biology |
3 |
|
microbiology and virulence |
3 |
|
molecular biology |
3 |
|
mouth mucosa - virology |
3 |
|
mouthwashes - therapeutic use |
3 |
|
nasopharyngeal neoplasms - radiotherapy |
3 |
|
national health programs - economics - statistics & numerical data |
3 |
|
neoplasms - blood supply - chemistry - metabolism - therapy |
3 |
|
new infection |
3 |
|
oral |
3 |
|
oral epithelial cells |
3 |
|
oral manifestations |
3 |
|
oropharynx - microbiology |
3 |
|
pathogenicity |
3 |
|
patient satisfaction |
3 |
|
periodontal diseases - microbiology |
3 |
|
pharyngeal diseases - microbiology |
3 |
|
polymers - administration & dosage |
3 |
|
private practice |
3 |
|
protective devices |
3 |
|
proteome - analysis |
3 |
|
proteomics |
3 |
|
quality of life |
3 |
|
radiation injuries - etiology - physiopathology - therapy |
3 |
|
radiotherapy |
3 |
|
recurrence |
3 |
|
review |
3 |
|
root canal therapy |
3 |
|
saliva, artificial - administration & dosage |
3 |
|
salivation |
3 |
|
secreted aspartic protease |
3 |
|
sequential isolates |
3 |
|
severe acute respiratory syndrome - prevention & control - psychology - transmission |
3 |
|
severity of illness index |
3 |
|
shedding |
3 |
|
single-blind method |
3 |
|
staphylococcal infections - complications |
3 |
|
therapeutics |
3 |
|
transforming growth factor beta1 - metabolism |
3 |
|
transforming growth factor-β1 |
3 |
|
treatment outcome |
3 |
|
virus shedding - physiology |
3 |
|
virus-loaded aerosol |
3 |
|
xerostomia |
3 |
|
xerostomia - etiology - physiopathology - therapy |
3 |
|
aids |
2 |
|
aids (disease) |
2 |
|
aids-related opportunistic infections - complications |
2 |
|
aluminum oxide - chemistry |
2 |
|
antifungal |
2 |
|
antifungal resistance |
2 |
|
antiretroviral therapy, highly active - adverse effects |
2 |
|
aspirin |
2 |
|
australia - epidemiology |
2 |
|
bacteria - classification - growth & development - isolation & purification |
2 |
|
biofilms - drug effects |
2 |
|
biotypes |
2 |
|
bisexuality |
2 |
|
buccal epithelial cells |
2 |
|
candida albicans - classification |
2 |
|
candida albicans - drug effects - physiology |
2 |
|
candida albicans - isolation & purification |
2 |
|
candida albicans - physiology |
2 |
|
candida species |
2 |
|
candidiasis, oral - complications |
2 |
|
candidiasis, oral - epidemiology - microbiology |
2 |
|
candidiasis, oral - ethnology - etiology |
2 |
|
candidiasis, oral - microbiology |
2 |
|
case-control studies |
2 |
|
catheter-related infection |
2 |
|
cd4 lymphocyte count |
2 |
|
cell adhesion |
2 |
|
cell count |
2 |
|
cell culture techniques |
2 |
|
ceramics |
2 |
|
coliforms |
2 |
|
dental etching - methods |
2 |
|
dental materials - chemistry |
2 |
|
disinfection/sterilization and lasers |
2 |
|
drug resistance, fungal |
2 |
|
england - epidemiology |
2 |
|
enterobacter cloacae - isolation & purification |
2 |
|
epithelial cells - microbiology |
2 |
|
flow rate |
2 |
|
germany - epidemiology |
2 |
|
gingiva - microbiology - pathology |
2 |
|
haart |
2 |
|
health expenditures - trends |
2 |
|
hiv |
2 |
|
hiv infections - complications - drug therapy - ethnology - pathology |
2 |
|
hiv infections - enzymology |
2 |
|
hiv infections - microbiology |
2 |
|
hiv infections - microbiology - pathology |
2 |
|
hiv-1 |
2 |
|
homosexuality |
2 |
|
homosexuality, male |
2 |
|
hong kong chinese |
2 |
|
hydrogen-ion concentration |
2 |
|
immune reconstitution inflammatory syndrome |
2 |
|
immune reconstitution inflammatory syndrome - complications - diagnosis - etiology - therapy |
2 |
|
indicators and reagents |
2 |
|
infection and aspirin |
2 |
|
leukoplakia, hairy - ethnology - etiology |
2 |
|
linear models |
2 |
|
lock therapy |
2 |
|
longitudinal studies |
2 |
|
lysozyme |
2 |
|
materials testing |
2 |
|
mouth - infections. |
2 |
|
mouth diseases - complications |
2 |
|
mouth diseases - ethnology - etiology |
2 |
|
mouth mucosa - microbiology |
2 |
|
muramidase - metabolism |
2 |
|
mycological typing techniques |
2 |
|
oral manifestations of general diseases. |
2 |
|
oral ulcer - ethnology - etiology |
2 |
|
oropharynx |
2 |
|
particle size |
2 |
|
ph |
2 |
|
pharmacology |
2 |
|
private sector - economics |
2 |
|
public sector - economics |
2 |
|
regression analysis |
2 |
|
saliva - chemistry - enzymology - secretion |
2 |
|
secretory rate |
2 |
|
stomatitis, herpetic - ethnology - etiology |
2 |
|
subgingival plaque |
2 |
|
surface properties |
2 |
|
surface roughness |
2 |
|
tetrazolium salts - diagnostic use |
2 |
|
tissue damage |
2 |
|
titanium - chemistry |
2 |
|
xerostomia - ethnology - etiology |
2 |
|
yeast |
2 |
|
zidovudine - therapeutic use |
2 |
|
acrylates |
1 |
|
acrylic |
1 |
|
adrenal insufficiency |
1 |
|
anemia, pernicious |
1 |
|
antifungal agents - pharmacology |
1 |
|
antifungal resistance. |
1 |
|
candida spp. |
1 |
|
cell adhesion - drug effects |
1 |
|
dentistry |
1 |
|
diabetes mellitus, type 1 - complications |
1 |
|
hiv protease inhibitors - pharmacology |
1 |
|
polyendocrinopathies, autoimmune |
1 |
|
polyendocrinopathies, autoimmune - diagnosis |
1 |
|
protease inhibitors |
1 |
|
secreted aspartyl proteinases |
1 |
|
surface treatments |
1 |
|
thyroiditis, autoimmune |
1 |
